DK1390371T3 - Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer - Google Patents

Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer

Info

Publication number
DK1390371T3
DK1390371T3 DK02740590T DK02740590T DK1390371T3 DK 1390371 T3 DK1390371 T3 DK 1390371T3 DK 02740590 T DK02740590 T DK 02740590T DK 02740590 T DK02740590 T DK 02740590T DK 1390371 T3 DK1390371 T3 DK 1390371T3
Authority
DK
Denmark
Prior art keywords
furopyrimidines
oxazolo
well
tumor drugs
formula
Prior art date
Application number
DK02740590T
Other languages
Danish (da)
English (en)
Inventor
Guido Bold
Andreas Martin-Kohler
Urs Sequin
Paul William Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1390371T3 publication Critical patent/DK1390371T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02740590T 2001-05-14 2002-05-13 Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer DK1390371T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8732001 2001-05-14

Publications (1)

Publication Number Publication Date
DK1390371T3 true DK1390371T3 (da) 2006-06-19

Family

ID=4544205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740590T DK1390371T3 (da) 2001-05-14 2002-05-13 Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer

Country Status (12)

Country Link
US (1) US7294633B2 (pt)
EP (1) EP1390371B1 (pt)
JP (1) JP4155827B2 (pt)
CN (1) CN100378107C (pt)
AT (1) ATE319718T1 (pt)
BR (1) BR0209645A (pt)
CA (1) CA2449188A1 (pt)
DE (1) DE60209721T2 (pt)
DK (1) DK1390371T3 (pt)
ES (1) ES2259707T3 (pt)
PT (1) PT1390371E (pt)
WO (1) WO2002092603A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689753A4 (en) * 2003-12-04 2010-07-07 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
US20080269238A1 (en) * 2004-04-01 2008-10-30 Takeda Pharmaceutical Company Limited Thiazolopyrimidine Derivative
EP1874769B1 (de) 2005-04-25 2011-09-14 Merck Patent GmbH Neuartige aza-heterozyklen als kinase-inhibitoren
DE102005061170A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
DE102005061171A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
CA2655895A1 (en) * 2006-06-22 2007-12-27 Nippon Chemiphar Co., Ltd. Agent for overcoming resistance to anti-cancer agent
DE102007019690A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007019691A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
DE102007027799A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
AU2009270511B2 (en) * 2008-07-15 2013-07-18 Sanofi Oxazolopyrimidines as Edg-1 receptor agonists
UY32240A (es) 2008-11-14 2010-06-30 Boeringer Ingelheim Kg Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
CN101899057A (zh) * 2010-07-21 2010-12-01 中国药科大学 嘧啶并噁唑衍生物的一种制备方法及其在医学上的用途
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
CN103087077B (zh) * 2011-11-03 2016-05-18 上海希迈医药科技有限公司 噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
CN103360407B (zh) * 2012-04-10 2016-06-22 上海希迈医药科技有限公司 一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
WO2015162518A1 (en) 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
CN104650111A (zh) * 2015-01-14 2015-05-27 中国药科大学 芳基脲及芳基酰胺取代的噁唑并嘧啶类化合物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137879A (en) 1990-03-30 1992-08-11 Dowelanco Furopyrimidin-4-imine derivatives
US5227387A (en) * 1991-09-03 1993-07-13 Dowelanco Quinoline nematicidal method
ES2109796T3 (es) * 1994-05-03 1998-01-16 Ciba Geigy Ag Derivados de pirrolopirimidilo con efecto antiproliferante.
JPH1184248A (ja) * 1997-09-12 1999-03-26 Nikon Corp 反射屈折縮小光学系
EP1777218B1 (en) * 2000-10-20 2008-12-31 Eisai R&D Management Co., Ltd. Process for the preparation of 4-phenoxy quinoline derivatives

Also Published As

Publication number Publication date
DE60209721T2 (de) 2006-09-07
JP2005508855A (ja) 2005-04-07
ATE319718T1 (de) 2006-03-15
CA2449188A1 (en) 2002-11-21
BR0209645A (pt) 2004-07-06
US20040152892A1 (en) 2004-08-05
CN1509291A (zh) 2004-06-30
US7294633B2 (en) 2007-11-13
EP1390371B1 (en) 2006-03-08
JP4155827B2 (ja) 2008-09-24
DE60209721D1 (de) 2006-05-04
CN100378107C (zh) 2008-04-02
WO2002092603A1 (en) 2002-11-21
EP1390371A1 (en) 2004-02-25
ES2259707T3 (es) 2006-10-16
PT1390371E (pt) 2006-07-31

Similar Documents

Publication Publication Date Title
DK1390371T3 (da) Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
ATE408601T1 (de) Fredericamycin-derivate
GB0022438D0 (en) Organic Compounds
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
CY1108129T1 (el) Παραγωγα 4-αμινο-6-φαινυλ-πυρρολο[2,3-δ]πυριμιδινης
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
CY1110247T1 (el) Παραγωγα βενζοκιναζολινης και η χρηση τους στην θεραπεια των διαταραχων των οστων
DE602004024375D1 (de) Carboxamidderivate
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
ECSP055844A (es) Nuevos compuestos triciclicos
NO20050640L (no) Rutenium anticancer komplekser
MXPA05012953A (es) Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
ATE429435T1 (de) 7h-pyrrolopyrimidinderivate
SE0002739D0 (sv) New use
TW200504051A (en) Novel acridine derivatives and their use as medicaments